L308-1590 Screening compound: N-(4-methylcyclohexyl)-3-{3-[4-(piperidine-1-sulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}propanamide

L308-1590 Screening compound: N-(4-methylcyclohexyl)-3-{3-[4-(piperidine-1-sulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}propanamide
L308-1590 Screening compound: N-(4-methylcyclohexyl)-3-{3-[4-(piperidine-1-sulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L308-1590
N-(4-methylcyclohexyl)-3-{3-[4-(piperidine-1-sulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L308-1590

Molecular Formula

C23H32N4O4S (C23 H32 N4 O4 S)

Compound Name

N-(4-methylcyclohexyl)-3-{3-[4-(piperidine-1-sulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}propanamide

IUPAC name

N-(4-methylcyclohexyl)-3-{3-[4-(piperidine-1-sulfonyl)phenyl]-124-oxadiazol-5-yl}propanamide

SMILES

CC(CC1)CCC1NC(CCc1nc(-c(cc2)ccc2S(N2CCCCC2)(=O)=O)no1)=O

InChI

InChI=1S/C23H32N4O4S/c1-17-5-9-19(10-6-17)24-21(28)13-14-22-25-23(26-31-22)18-7-11-20(12-8-18)32(29,30)27-15-3-2-4-16-27/h7-8,11-12,17,19H,2-6,9-10,13-16H2,1H3,(H,24,28)

InChI Key

KXZDOANIQHBNFF-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27243896

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

460.6

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.654

Distribution Coefficient, logD

4.654

Water Solubility, LogSw

-4.22

Polar Surface Area

87.218

Acid Dissociation Constant (pKa)

15.48

Base Dissociation Constant (pKb)

1.45

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

60.90

L308-1590 in Drug Discovery

Included in Screening Libraries

GABA Library (7115 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
Targets:
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with L308-1590 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L308-1590?
Check Price and Availability of L308-1590, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L308-1590 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L308-1590
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L308-1590
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L308-1590 available by request